Table II.

Nucleic Acid Detection of Respiratory Viruses in Clinical Specimens From Patients With Respiratory Symptoms

Respiratory viruses	Patients, n (%)
hMPV	21 (5.4%)
RSV	13 (4%)
Adenoviruses	10 (3%)
Influenza‐A	5 (1.3%)
Influenza‐B	1 (0.3%)
Rhinoviruses	29 (7.5%)
PIV‐1	10 (3%)
PIV‐2	0
PIV‐3	6 (1.5%)
Corona‐229E	1 (0.3%)
Corona‐OC43	0
hMPV/Rhinovirus	3 (1%)
hMPV/Adenovirus	1 (0.3%)
Rhinovirus/RSV	2 (0.5%)
Rhinovirus/Adenovirus	1 (0.3%)
Rhinovirus/PIV‐1	1 (0.3%)
Rhinovirus/PIV‐3	2 (0.5%)
PIV‐1/PIV‐3	4 (1%)
Total	110 (28%)

hMPV, human metapneumovirus; RSV, respiratory Syncytial virus; PIV, parainfluenza virus.